Cytosorbents (CTSO) Consolidated Net Income (2010 - 2026)
Cytosorbents' (CTSO) quarterly Consolidated Net Income came in at -$11.0 million in Q1 2026, down 646.77% YoY from $2.0 million in Q1 2025, and down 169.79% on a QoQ basis from -$4.1 million in Q4 2025.
Cytosorbents (CTSO) Consolidated Net Income (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Consolidated Net Income data on file, last reported at -$11.0 million in Q1 2026.
- Quarterly Consolidated Net Income fell 646.77% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$43.5 million (down 892.28% YoY) and the FY2025 annual result came in at -$6.8 million, up 24.49% from the prior year.
- Consolidated Net Income fell to -$11.0 million in Q1 2026, from -$4.1 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $4.2 million in Q4 2024 to a low of -$25.2 million in Q2 2025.
- A 5-year average of -$6.8 million and a median of -$6.1 million in 2023 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2023 — Consolidated Net Income plunged 700.76% — and 2024, when it surged 167.74%.
- Tracing CTSO's Consolidated Net Income over 5 years: stood at -$766126.0 in 2022, then slumped by 700.76% to -$6.1 million in 2023, then surged by 167.74% to $4.2 million in 2024, then sank by 198.46% to -$4.1 million in 2025, then tumbled by 169.79% to -$11.0 million in 2026.
- The last three Consolidated Net Income figures came in at -$11.0 million (Q1 2026), -$4.1 million (Q4 2025), and -$3.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Cytosorbents | 21.57 Mn | 17.16 Mn | 7.05 Mn | -3.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.52 Mn |
| Mar 31, 2026 | -11.04 Mn |
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -25.21 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Dec 31, 2023 | -6.13 Mn |
| Sep 30, 2023 | -9.19 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -7.32 Mn |
| Dec 31, 2022 | -766,126.00 |
| Sep 30, 2022 | -12.20 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -8.97 Mn |
| Dec 31, 2021 | -9.31 Mn |
| Sep 30, 2021 | -6.41 Mn |